Inflammatory Markers in Infants With Obstructive Sleep Apnea
1 other identifier
observational
100
1 country
1
Brief Summary
Obstructive sleep apnea syndrome (OSAS) is a common disorder in children (2-3%). OSAS in turn, is associated with significant behavioral, learning, and heart problems. Adenotonsillectomy (T\&A, meaning the removal of tonsils and adenoids) is the most common treatment for the problem .Diagnosis of OSAS in children is based on overnight polysomnography (sleep study). Recent studies suggest that upper airway and systemic inflammatory changes exists in school-age children and adults with OSAS, and that anti inflammatory therapy can improve respiratory parameters during sleep and reduce adenoid size, similar to surgery. However, there are no data in the literature on inflammatory changes in infants with the disorder. Healthcare resources utilization, a sensitive marker for diseases is consumed by young children (\<3y) with OSAS more then healthy children, from their first year of life We hypothesize that infants and young children with OSAS present local inflammatory changes of the airways as well as systemic inflammation (in the blood or urine) that contribute to the learning, growing and heart associated medical problems. The Aims of the present study are to characterize the local and systemic inflammatory changes of young children with OSAS, and to evaluate their associated medical problems at diagnosis and after therapy (T\&A) If indeed inflammation is "responsible" for the development of OSAS at such a young age it should be reduced following therapy (i.e. T\&A). In such a case bio-markers may become a part of the algorithms for diagnosis and follow up of such patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Feb 2010
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 27, 2010
CompletedFirst Posted
Study publicly available on registry
January 28, 2010
CompletedStudy Start
First participant enrolled
February 1, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2012
CompletedJanuary 28, 2010
January 1, 2010
1 year
January 27, 2010
January 27, 2010
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Analysis of average change in inflammatory markers, before -to-after T%A.
February 2011
Eligibility Criteria
Children aged 0-3 years diagnosed with obstructive sleep apnea syndrome, refferred to removal of tonsills and adenoids
You may qualify if:
- Children aged 1 month-3 years
- Diagnosis of obstructive sleep apnea syndrome(according to a sleep study)
You may not qualify if:
- Congenital disorders of the respiratory system
- Congenital craniofacial disorders (retrognathia, Trisomy 21)
- Use of anti inflammatory medications (like: montelukast, budesonide) up to 4 weeks prior to study entry.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Soroka UMC
Beersheba, 84101, Israel
Related Publications (1)
Goldbart AD, Tal A. Inflammation and sleep disordered breathing in children: a state-of-the-art review. Pediatr Pulmonol. 2008 Dec;43(12):1151-60. doi: 10.1002/ppul.20943.
PMID: 19009600BACKGROUND
Biospecimen
Serum and urine will be obtained before therapy (T%A) snd 3 months afterwards. The serum will be stored at -70 throughout the study in the PI's Lab (DR.Goldbart) At the end of the study the sampled will be assessed for the presence of inflammatory markers (cytokines).
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Aviv D Goldbart, MD
Soroka UMC
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
January 27, 2010
First Posted
January 28, 2010
Study Start
February 1, 2010
Primary Completion
February 1, 2011
Study Completion
February 1, 2012
Last Updated
January 28, 2010
Record last verified: 2010-01